CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		118,747,447
Beginning balance at Dec. 31, 2021	$ 32,807,995	$ 118,748	$ 176,586,529	$ (143,951,019)	$ 53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,089,263)			(2,089,263)
Unrealized gain (loss) on debt securities	(98,156)				(98,156)
Stock-based compensation	671,158		671,158
Stock issued for vested restricted stock awards (in shares)		1,059,755
Stock issued for vested restricted stock awards	0	$ 1,060	(1,060)
Shares withheld for taxes on vested restricted stock	(128,520)		(128,520)
Stock warrants issued for referral agreement	12,483		12,483
Ending balance (in shares) at Mar. 31, 2022		119,807,202
Ending balance at Mar. 31, 2022	31,175,697	$ 119,808	177,140,590	(146,040,282)	(44,419)
Beginning balance (in shares) at Dec. 31, 2021		118,747,447
Beginning balance at Dec. 31, 2021	32,807,995	$ 118,748	176,586,529	(143,951,019)	53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,129,756)
Unrealized gain (loss) on debt securities	(186,239)
Ending balance (in shares) at Sep. 30, 2022		120,137,124
Ending balance at Sep. 30, 2022	25,214,581	$ 120,138	178,307,716	(153,080,771)	(132,502)
Beginning balance (in shares) at Mar. 31, 2022		119,807,202
Beginning balance at Mar. 31, 2022	31,175,697	$ 119,808	177,140,590	(146,040,282)	(44,419)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,229,927)			(3,229,927)
Unrealized gain (loss) on debt securities	(124,253)				(124,253)
Stock-based compensation	684,376		684,376
Stock issued for vested restricted stock awards (in shares)		66,666
Stock issued for vested restricted stock awards	0	$ 66	(66)
Stock warrants issued for referral agreement	462		462
Ending balance (in shares) at Jun. 30, 2022		119,873,868
Ending balance at Jun. 30, 2022	28,506,355	$ 119,874	177,825,362	(149,270,209)	(168,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,810,562)			(3,810,562)
Unrealized gain (loss) on debt securities	36,170				36,170
Stock-based compensation	535,458		535,458
Stock issued for vested restricted stock awards (in shares)		263,256
Stock issued for vested restricted stock awards	0	$ 264	(264)
Shares withheld for taxes on vested restricted stock	(68,372)		(68,372)
Stock warrants issued for referral agreement	15,532		15,532
Ending balance (in shares) at Sep. 30, 2022		120,137,124
Ending balance at Sep. 30, 2022	25,214,581	$ 120,138	178,307,716	(153,080,771)	(132,502)
Beginning balance (in shares) at Dec. 31, 2022		120,137,124
Beginning balance at Dec. 31, 2022	21,749,316	$ 120,138	178,771,604	(157,057,558)	(84,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,440,105)			(3,440,105)
Unrealized gain (loss) on debt securities	84,868				84,868
Stock-based compensation	432,084		432,084
Stock issued for vested restricted stock awards (in shares)		1,503,238
Stock issued for vested restricted stock awards	0	$ 1,503	(1,503)
Shares withheld for taxes on vested restricted stock	(166,872)		(166,872)
Reversal of expense related to a change in warrant vesting	(9,874)		(9,874)
Ending balance (in shares) at Mar. 31, 2023		121,640,362
Ending balance at Mar. 31, 2023	18,649,417	$ 121,641	179,025,439	(160,497,663)	0
Beginning balance (in shares) at Dec. 31, 2022		120,137,124
Beginning balance at Dec. 31, 2022	21,749,316	$ 120,138	178,771,604	(157,057,558)	(84,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,988,323)
Unrealized gain (loss) on debt securities	84,868
Ending balance (in shares) at Sep. 30, 2023		137,983,918
Ending balance at Sep. 30, 2023	18,868,678	$ 137,983	183,776,576	(165,045,881)	0
Beginning balance (in shares) at Mar. 31, 2023		121,640,362
Beginning balance at Mar. 31, 2023	18,649,417	$ 121,641	179,025,439	(160,497,663)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,377,238)			(3,377,238)
Unrealized gain (loss) on debt securities	0
Stock-based compensation	503,061		503,061
Stock issued for vested restricted stock awards (in shares)		3,333
Stock issued for vested restricted stock awards	0	$ 3	(3)
Stock warrants issued for referral agreement	1,276		1,276
Capital raise, net of issuance costs (in shares)		16,000,000
Capital raise, net of issuance costs	3,665,000	$ 16,000	3,649,000
AGP Closing at-the-market sale (in shares)		173,558
AGP Closing at-the-market sale	61,136	$ 174	60,962
Ending balance (in shares) at Jun. 30, 2023		137,817,253
Ending balance at Jun. 30, 2023	19,502,652	$ 137,818	183,239,735	(163,874,901)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,170,980)			(1,170,980)
Unrealized gain (loss) on debt securities	0
Stock-based compensation	536,538		536,538
Stock issued for vested restricted stock awards (in shares)		166,665
Stock issued for vested restricted stock awards	0	$ 165	(165)
Stock warrants issued for referral agreement	468		468
Ending balance (in shares) at Sep. 30, 2023		137,983,918
Ending balance at Sep. 30, 2023	$ 18,868,678	$ 137,983	$ 183,776,576	$ (165,045,881)	$ 0